Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lumexa Imaging HoldingsLMRI +4.18%9 EV-to-EBIT is 94.20 as of Aug. 13, 2026, which is 119% above its 10-year median of 43.05. GuruFocus rates LMRI with a GF Score™ of 9/100. The stock has 2 warning signs investors should review. Among 471 Medical Devices & Instruments companies, Lumexa Imaging Holdings ranks worse than 91.51% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Lumexa Imaging Holdings's Enterprise Value for the quarter that ended in Mar. 2026 was $1,742.5 Mil.
Lumexa Imaging Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $22.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lumexa Imaging Holdings EV-to-EBIT Related Terms
Lumexa Imaging Holdings EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Lumexa Imaging Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lumexa Imaging Holdings EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lumexa Imaging Holdings's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Lumexa Imaging Holdings's EV-to-EBIT falls into.
Lumexa Imaging Holdings's current Enterprise Value is $2,088.4 Mil.
Lumexa Imaging Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $22.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lumexa Imaging Holdings (LMRI) has a EV-to-EBIT of 94.20 as of Aug. 13, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Lumexa Imaging Holdings and its competitors. This is 119% above median its historical median of 43.05. Over the past decade, Lumexa Imaging Holdings' EV-to-EBIT has ranged from 33.35 to 95.45. According to the industry distribution chart, Lumexa Imaging Holdings ranks #431 out of 471 companies in the Medical Devices & Instruments industry, placing it in the top 91.5%.
Is Lumexa Imaging Holdings' EV-to-EBIT too high?
Lumexa Imaging Holdings' current EV-to-EBIT of 94.20 is 119% above median its 10-year median of 43.05. Over the past 10 years, this metric has ranged from a low of 33.35 to a high of 95.45. The Medical Devices & Instruments industry median EV-to-EBIT is 19.17. Lumexa Imaging Holdings' value of 94.20 is 391.4% above this industry median. Based on the distribution chart, Lumexa Imaging Holdings ranks #431 out of 471 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Lumexa Imaging Holdings has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Lumexa Imaging Holdings' EV-to-EBIT compare to QDEL and PRCT?
According to the Medical Devices & Instruments industry distribution chart, Lumexa Imaging Holdings ranks #431 out of 471 companies for EV-to-EBIT. This places Lumexa Imaging Holdings in the lower half of its industry. The industry median EV-to-EBIT is 19.17. Lumexa Imaging Holdings' value of 94.20 is 391.4% above this benchmark. Historically, Lumexa Imaging Holdings' own EV-to-EBIT has ranged from 33.35 to 95.45 over the past decade. While the company's 10-year median is 43.05 vs. the industry median of 19.17, Lumexa Imaging Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 19.17, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lumexa Imaging Holdings's current EV-to-EBIT of 94.20 is 391.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Lumexa Imaging Holdings and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 19.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lumexa Imaging Holdings's current EV-to-EBIT is 94.20, which is 119% above median its own 10-year median of 43.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lumexa Imaging Holdings stock overvalued right now?
Lumexa Imaging Holdings (LMRI) has a current EV-to-EBIT of 94.20. The current EV-to-EBIT is 94.20, which is 119% above median its 10-year median of 43.05 and 391.4% above the Medical Devices & Instruments industry median of 19.17. Lumexa Imaging Holdings' overall GF Score™ is 9/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Lumexa Imaging Holdings (LMRI), the current EV-to-EBIT is 94.20 as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.
9GF Score
Get the complete analysis for LMRI
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LMRI has been successfully added to your 
